Repligen price target lowered to $210 from $225 at Stifel

Stifel analyst Daniel Arias lowered the firm’s price target on Repligen to $210 from $225 and keeps a Buy rating on the shares. There "appear to be pockets of encouraging demand at the moment," but within an overall business that is "clearly still finding its footing," says the analyst, who adds that management’s re-calibrated outlook "should reflect the current state of the market."